About
Periodic safety update report single assessments (PSUSAs) are single assessments of related periodic safety update reports (PSURs) for active substances contained in medicines authorised in the European Union (EU). A PSUR is a pharmacovigilance report submitted regularly by a marketing-authorisation holder at defined time points following a medicine's authorisation.
Key facts
- Active substance(s) in scope of the PSUSA procedure
- levosalbutamol, salbutamol
- Procedure number
- PSUSA/000010330/202301
- Regulatory outcome
- Variation
Documents
Levosalbutamol, salbutamol : List of nationally authorised medicinal products - PSUSA/000010330/202301
English (EN) (330.05 KB - PDF)
Levosalbutamol, salbutamol : CMDh Scientific conclusions and grounds for variation, amendments to the product information and timetable for the implementation - PSUSA/00010330/202301
English (EN) (134.07 KB - PDF)
български (BG) (224.66 KB - PDF)
español (ES) (192.94 KB - PDF)
čeština (CS) (232.11 KB - PDF)
dansk (DA) (191.02 KB - PDF)
Deutsch (DE) (186.14 KB - PDF)
eesti keel (ET) (210.4 KB - PDF)
ελληνικά (EL) (129.17 KB - PDF)
français (FR) (143.02 KB - PDF)
hrvatski (HR) (241.06 KB - PDF)
íslenska (IS) (176.69 KB - PDF)
italiano (IT) (112.86 KB - PDF)
latviešu valoda (LV) (143.02 KB - PDF)
lietuvių kalba (LT) (215.92 KB - PDF)
magyar (HU) (162.14 KB - PDF)
Malti (MT) (137.15 KB - PDF)
Nederlands (NL) (117.77 KB - PDF)
norsk (NO) (198.92 KB - PDF)
polski (PL) (218.13 KB - PDF)
português (PT) (189.07 KB - PDF)
română (RO) (257.04 KB - PDF)
slovenčina (SK) (241.93 KB - PDF)
slovenščina (SL) (252.71 KB - PDF)
Suomi (FI) (186.92 KB - PDF)
svenska (SV) (183.82 KB - PDF)